Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 1.20p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.96
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 1,401.82m
  • Volume: 0
  • Market Cap: £16.82m
  • RiskGrade: 340
  • Beta: 0.73

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 75,090,685 £901,088
Vladislav Sandler Ph.D. 41,544,677 £498,536
Peter Redmond 5,596,270 £67,155

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 75,090,685 £901,088
Dr Vladislav Sandler 41,544,677 £498,536
Optiva Securities Limited 28,131,723 £337,581
Flascherberg Capital Anstalt 27,996,487 £335,958
Craig Auringer 23,837,250 £286,047
HSBC Client Holdings Nominee (UK) Limited 18,063,805 £216,766
Ron Valk 17,131,193 £205,574
Samantha Bauer 17,082,201 £204,986
Plum Capital 11,692,863 £140,314
43 North LLC 11,371,429 £136,457
Abdelatif LACHAB 2,600,000 £31,200
Wayne Gibson 2,600,000 £31,200

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.20p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.96
52 Week Low 0.88
Volume 0
Shares Issued 1,401.82m
Market Cap £16.82m
Beta 0.73
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average
72% below the sector average72% below the sector average72% below the sector average72% below the sector average72% below the sector average
Price Trend
6.02% above the market average6.02% above the market average6.02% above the market average6.02% above the market average6.02% above the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page